by Truveta staff | Apr 21, 2025 | Data
Asthma is one of the most studied chronic diseases in medicine, yet decades into the biologics era, researchers face familiar frustrations. Limited phenotyping, unpredictable treatment responses, persistent health disparities, and slow insight cycles can’t meet...
by Truveta staff | Mar 20, 2025 | Data
Why autoimmune research needs better real-world data Biologics like Humira, Enbrel, and Rinvoq have transformed autoimmune treatment, revolutionizing treatment for patients with chronic inflammatory infections. However, the traditional methods of studying these...
by Truveta Research | Aug 6, 2024 | Research, Research Insights
Authors: Patricia J. Rodriguez, PhD MPH ⊕Truveta, Inc, Bellevue, WA, Brianna M. Goodwin Cartwright ⊕Truveta, Inc, Bellevue, WA, Samuel Gratzl PhD ⊕Truveta, Inc, Bellevue, WA, Charlotte Baker DrPH MPH CPH ⊕Truveta, Inc, Bellevue, WA, Nicholas Stucky, MD PhD ⊕Truveta,...
